AiCuris AG Appoints Larry Edwards as CEO
Edwards took over the role on April 1, 2023.
AICuris Anti-infective Cures AG announced that Larry Edwards is the company's new CEO. He will also be president of AiCuris U.S. Inc., where he will be responsible for establishing the company's U.S. presence.
Former CEO Dr. Holger Zimmerman is moving to a new role as chief research and development officer.
New machine-learning approach could speed precision drug development
The approach, detailed this week in the journal Nature, uses a platform called Molecular Surface Interaction Fingerprinting (MaSIF) to design custom proteins that bind to drug-bound target proteins.
AI-enabled CGM app shows promise for glycemic control, weight management
The broader implications of this study suggest that digital health platforms like January V2 have the potential to play a crucial role in the future of chronic disease management,” the authors write.
